BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3095891)

  • 41. [The EQUAL-ESTRO external quality control laboratory in France].
    Roué A; Van Dam J; Dutreix A; Svensson H
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S44-9. PubMed ID: 15679246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dosimetric audits of photon beams in radiation therapy centres in Rio de Janeiro, Brazil.
    da Rosa LA; Brito RR; Gonçalves M; de Paiva E; Dovales AC; Freire BL; Giannoni RA; Di Prinzio R; Velasco AF; Castelo LH; Oliveira RV
    Radiat Prot Dosimetry; 2008; 131(2):272-5. PubMed ID: 18503063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production, review, and impact of technical quality control guidelines in a national context.
    Nielsen MK; Malkoske KE; Brown E; Diamond K; Frenière N; Grant J; Pomerleau-Dalcourt N; Schella J; Schreiner LJ; Tantôt L; Villareal-Barajas JE; Bissonnette JP
    J Appl Clin Med Phys; 2016 Nov; 17(6):3-15. PubMed ID: 27929477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Result of the onsite dosimetry and questioning about quality assurance/ quality control of radiotherapy in the Hokuriku area - a comparison with past results -].
    Takemura A; Tsukamoto N; Yamamoto E; Ueda S; Kurata Y; Kato S; Nishijima A; Matsukura A; Koshida K; Amano R
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2010 Sep; 66(9):1213-20. PubMed ID: 20975242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Twenty five years of the National Academy of Medical Sciences of Ukraine - progress and priorities for future of radiation medicine and biology.
    Bazyka D
    Probl Radiac Med Radiobiol; 2017 Dec; 22():10-14. PubMed ID: 29286493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of the modifications in the quality assurance system in radiotherapy in the example of in-vivo dosimetry.
    Malicki J; Litoborski M; Bogusz-Czerniewicz M; Swiezewski A
    Phys Med; 2009 Dec; 25(4):201-6. PubMed ID: 19286407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A quality assurance program for simulators in radiotherapy. 1: The universal phantom for quality control of therapy simulators and teletherapy equipment].
    Baltas D; Müller-Sievers K; Kober B
    Strahlenther Onkol; 1993 May; 169(5):296-303. PubMed ID: 8503089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of transit in vivo dosimetry using portal imaging and comparison with measurements using diodes].
    Royer P; Marchesi V; Rousseau V; Buchheit I; Wolf D; Peiffert D; Noël A
    Cancer Radiother; 2014 Jun; 18(3):183-90. PubMed ID: 24792230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status of kilovoltage (kV) radiotherapy in the UK: installed equipment, clinical workload, physics quality control and radiation dosimetry.
    Palmer AL; Pearson M; Whittard P; McHugh KE; Eaton DJ
    Br J Radiol; 2016 Dec; 89(1068):20160641. PubMed ID: 27730839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ÖGRO survey on radiotherapy capacity in Austria : Status quo and estimation of future demands.
    Zurl B; Bayerl A; De Vries A; Geinitz H; Hawliczek R; Knocke-Abulesz TH; Lukas P; Pötter R; Raunik W; Scholz B; Schratter-Sehn A; Sedlmayer F; Seewald D; Selzer E; Kapp KS
    Strahlenther Onkol; 2018 Apr; 194(4):284-292. PubMed ID: 29222711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimum requirements for quality assurance in radiotherapy.
    Seelentag W; Garavaglia G
    Radiother Oncol; 1994 Aug; 32(2):184-5. PubMed ID: 7972913
    [No Abstract]   [Full Text] [Related]  

  • 52. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.
    Ataman F; Poortmans P; Davis JB; Bernier J; Giraud JY; Kouloulias VE; Pierart M; Bolla M
    Eur J Cancer; 2004 Nov; 40(16):2411-6. PubMed ID: 15519513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The determination of phantom and collimator scatter components of the output of megavoltage photon beams: measurement of the collimator scatter part with a beam-coaxial narrow cylindrical phantom.
    van Gasteren JJ; Heukelom S; van Kleffens HJ; van der Laarse R; Venselaar JL; Westermann CF
    Radiother Oncol; 1991 Apr; 20(4):250-7. PubMed ID: 1906190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire.
    Weber DC; Abrunhosa-Branquinho A; Bolsi A; Kacperek A; Dendale R; Geismar D; Bachtiary B; Hall A; Heufelder J; Herfarth K; Debus J; Amichetti M; Krause M; Orecchia R; Vondracek V; Thariat J; Kajdrowicz T; Nilsson K; Grau C
    Radiother Oncol; 2017 Aug; 124(2):185-189. PubMed ID: 28764925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of initial quality control review on study outcome in lung and head/neck cancer studies--review of the Radiation Therapy Oncology Group experience.
    Wallner PE; Lustig RA; Pajak TF; Robinson G; Davis LW; Perez CA; Seydel HG; Marcial VA; Laramore GE
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):893-900. PubMed ID: 2674086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey.
    Horiot JC; van den Bogaert W; Ang KK; Van der Schueren E; Bartelink H; Gonzalez D; de Pauw M; van Glabbeke M
    Front Radiat Ther Oncol; 1988; 22():149-61. PubMed ID: 3280411
    [No Abstract]   [Full Text] [Related]  

  • 57. An evaluation of epoxy resin phantom materials for megavoltage photon dosimetry.
    Allahverdi M; Nisbet A; Thwaites DI
    Phys Med Biol; 1999 May; 44(5):1125-32. PubMed ID: 10368006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dosimetric inter-institutional comparison in European radiotherapy centres: Results of IAEA supported treatment planning system audit.
    Gershkevitsh E; Pesznyak C; Petrovic B; Grezdo J; Chelminski K; do Carmo Lopes M; Izewska J; Van Dyk J
    Acta Oncol; 2014 May; 53(5):628-36. PubMed ID: 24164104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
    Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T
    J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recommendations for clinical electron beam dosimetry: supplement to the recommendations of Task Group 25.
    Gerbi BJ; Antolak JA; Deibel FC; Followill DS; Herman MG; Higgins PD; Huq MS; Mihailidis DN; Yorke ED; Hogstrom KR; Khan FM
    Med Phys; 2009 Jul; 36(7):3239-79. PubMed ID: 19673223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.